Circulating KCNH2 Activating Factor in Heart Failure Patients
Author Information
Author(s): Hiroki Sugiyama, Kazufumi Nakamura, Hiroshi Morita, Satoshi Akagi, Yoshinori Tani, Yusuke Katayama, Nobuhiro Nishii, Toru Miyoshi, Satoshi Nagase, Kunihisa Kohno, Kengo Kusano, Tohru Ohe, Junko Kurokawa, Tetsushi Furukawa, Hiroshi Ito
Primary Institution: Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Hypothesis
Is there a circulating KCNH2 current-modifying factor in patients with heart failure?
Conclusion
The study provides evidence for a circulating KCNH2 channel activator in patients with heart failure and ventricular tachyarrhythmias.
Supporting Evidence
- The study found that serum from heart failure patients with ventricular arrhythmia significantly enhanced KCNH2 currents.
- Eight patients had documented ventricular tachyarrhythmias, indicating a high risk of arrhythmia.
- The mean QTc interval was longer in heart failure patients compared to controls.
Takeaway
Doctors found a special factor in the blood of heart failure patients that can make heart cells more likely to have dangerous rhythms.
Methodology
The study used whole-cell patch-clamp technique to examine the effects of serum from heart failure patients on recombinant KCNH2 currents.
Potential Biases
Potential bias due to the selection of patients and the specific conditions of the study.
Limitations
The study had a small sample size and was limited to specific patient demographics.
Participant Demographics
14 heart failure patients (mean age 52 years, 57% male) and 6 normal controls (mean age 43 years, 67% male).
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website